Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P 500 Healthcare Sector SPDR (XLV)

S&P 500 Healthcare Sector SPDR (XLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XLV with:
  • Price/Earnings ttm 16.67
  • Annual Dividend & Yield 2.23 (1.50%)
  • Most Recent Dividend 0.573 on 06/24/24
  • Management Fee 0.10%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 12.59% ( -2.84%)
  • Historical Volatility 10.60%
  • IV Percentile 56%
  • IV Rank 44.07%
  • IV High 20.69% on 08/31/23
  • IV Low 6.22% on 02/06/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 11,989
  • Volume Avg (30-Day) 14,119
  • Put/Call OI Ratio 1.32
  • Today's Open Interest 321,925
  • Open Int (30-Day) 296,305

Price Performance

See More
Period Period Low Period High Performance
1-Month
142.73 +5.07%
on 07/03/24
151.53 -1.04%
on 07/25/24
+3.85 (+2.64%)
since 06/26/24
3-Month
139.55 +7.46%
on 05/01/24
151.53 -1.04%
on 07/25/24
+10.00 (+7.14%)
since 04/26/24
52-Week
122.59 +22.33%
on 10/27/23
151.53 -1.04%
on 07/25/24
+14.17 (+10.44%)
since 07/26/23

Most Recent Stories

More News
Solventum’s Q2 2024 Earnings: What to Expect

Solventum is gearing up to unveil its second-quarter earnings next month. Here’s what analysts are predicting.

SOLV : 57.63 (+0.14%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
3 Surprisingly Underrated Stocks to Buy Right Now

These stocks arguably deserve more respect from investors.

XLV : 149.96 (+0.56%)
AZN : 78.13 (-0.50%)
PFE : 30.77 (+3.39%)
VTRS : 12.08 (+2.72%)
What to Expect From CVS Health's Q2 2024 Earnings Report

CVS Health is all set to announce its second-quarter results next month, and analysts are projecting a double-digit decline in the company’s bottom-line figure.

CVS : 61.00 (+4.01%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
IDEXX Laboratories Earnings Preview: What to Expect

IDEXX Laboratories will unveil its Q2 earnings next month, and analysts anticipate a single-digit bottom-line growth.

IDXX : 469.71 (-0.21%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
STERIS’ Quarterly Earnings Preview: What You Need to Know

STERIS will unveil its Q1 earnings next month, and analysts project a single-digit bottom-line growth.

STE : 232.79 (+2.30%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
ResMed Earnings Preview: What to Expect

ResMed will release its fourth-quarter earnings next month, and analysts anticipate a double-digit profit growth.

RMD : 197.04 (-5.42%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
LLY : 804.62 (-2.02%)
What to Expect From Henry Schein's Next Quarterly Earnings Report

With Henry Schein expected to release its Q2 earnings next month, analysts project a single-digit profit dip.

HSIC : 72.31 (+1.79%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
Earnings Preview: What to Expect From Zimmer Biomet’s Report

Zimmer Biomet will release its second-quarter earnings next month, and analysts anticipate a single-digit profit growth.

ZBH : 111.29 (+0.59%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
Insulet's Q2 2024 Earnings: What to Expect

Insulet will release its second-quarter earnings next month, and analysts anticipate double-digit bottom-line growth.

PODD : 193.30 (+1.27%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)
Zoetis Earnings Preview: What to Expect

As Zoetis is all set to announce its second-quarter earnings next month, analysts project a single-digit improvement in its bottom line.

ZTS : 179.84 (-0.51%)
$SPX : 5,459.10 (+1.11%)
XLV : 149.96 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.

See More

Key Turning Points

3rd Resistance Point 152.84
2nd Resistance Point 151.89
1st Resistance Point 150.92
Last Price 149.96
1st Support Level 149.00
2nd Support Level 148.05
3rd Support Level 147.08

See More

52-Week High 151.53
Last Price 149.96
Fibonacci 61.8% 140.47
Fibonacci 50% 137.06
Fibonacci 38.2% 133.65
52-Week Low 122.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar